CRIO Secures Series A Financing to Accelerate Growth and Platform Development
News provided by
Share this article
Share this article
BOSTON, March 11, 2021 /PRNewswire/ Clinical Research IO (CRIO), a Boston-based technology firm offering clinical research sponsors and sites a platform to streamline clinical trials, announced the completion of a $3.5 million Series A round led by Rally Ventures.
The round allows CRIO to expand its product and engineering teams to develop the next wave of products. Our goal has always been to streamline clinical research, said Raymond Nomizu, company co-founder and CEO. To do this, we need to ramp up our product and engineering teams. We have laid the groundwork with our unparalleled site network of electronic adopters, and now we want to leverage this to unlock efficiencies for sponsors and contract research organizations (CROs).
CRIO Secures Series A Financing to Accelerate Growth and Platform Development
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
A false dawn or green revolution? Picking apart the UK Government s ten-point plan
professionaladviser.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from professionaladviser.com Daily Mail and Mail on Sunday newspapers.
A false dawn or green revolution? Picking apart the UK Government s ten-point plan
Jumpstarting funding for clean energy infrastructure
Among the policies is a ban on the sale of new petrol and diesel cars from 2030
The UK Government s ten-point plan for a green industrial revolution is pushing investors to funnel money into green infrastructure, but fund managers warn this will not necessarily amount to sure-fire investment success.
The new raft of environmental policies, which were first announced in November last year, aims to mobilise £12bn of government investment and potentially more than three times that amount from the private.
To continue reading.